Invention Grant
- Patent Title: Pyrrolo[2,3-d]pyrimidine compounds
- Patent Title (中): 吡咯并[2,3-d]嘧啶化合物
-
Application No.: US12542451Application Date: 2009-08-17
-
Publication No.: US08133899B2Publication Date: 2012-03-13
- Inventor: Mark J. Mitton-Fry , Pamela J. Berlinski , Matthew J. Birchmeier , Jerry W. Bowman , Andrea Joy Gonzales , Steven Glenn Kamerling , Donald Wayne Mann
- Applicant: Mark J. Mitton-Fry , Pamela J. Berlinski , Matthew J. Birchmeier , Jerry W. Bowman , Andrea Joy Gonzales , Steven Glenn Kamerling , Donald Wayne Mann
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Lucy X. Yang
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/519 ; C07D487/00
![Pyrrolo[2,3-d]pyrimidine compounds](/abs-image/US/2012/03/13/US08133899B2/abs.jpg.150x150.jpg)
Abstract:
Described herein is pyrrolo{2,3-d}pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing this compounds, and methods for the preparation of these compounds.
Public/Granted literature
- US20100075996A1 PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS Public/Granted day:2010-03-25
Information query
IPC分类: